Stephani Amstadter
Family Medicine · Lakewood, WANPI 1750329777
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 8.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,038 and has fallen 97.5% since, to $26 in 2024.
Across 79 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$124
- Amgen$122
- Coopersurgical, Inc.$114
- Novo Nordisk$108
- AstraZeneca$103
- Pfizer$84
- plus $790 from 18 others
What the payments were for
- Food & beverage$1,445100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $124 |
| Amgen(2 entities) | 6 | $122 |
| Coopersurgical, Inc. | 2 | $114 |
| Novo Nordisk | 6 | $108 |
| AstraZeneca | 6 | $103 |
| Pfizer | 5 | $84 |
| Lilly USA, LLC | 5 | $79 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| GSK | 4 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Astellas Pharma US Inc | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $51 |
| Boehringer Ingelheim | 2 | $50 |
| Johnson & Johnson | 2 | $48 |
| Merck | 3 | $47 |
| Galderma Laboratories, L.p. | 2 | $47 |
| Mylan Specialty L.p. | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $25 |
| Novartis | 2 | $25 |
| Therapeuticsmd, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Lupin Inc. | 1 | $16 |
How this compares
$1,445 in reported general payments places this provider in the 85th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Lakewood
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.